Prasco to distribute GSK generics

Ohio, USA-based Prasco Laboratories has entered into a marketing and distribution agreement with UK drug giant GlaxoSmithKline for generics,  with Flonase (fluticasone propionate) nasal spray the first product to  be marketed under this deal. Prasco, as GSK's agent and on its behalf,  will solicit orders for, and distribute fluticasone propionate nasal  spray to all trade classes in the USA under a GSK/Prasco label.

"We are especially proud to have established this relationship with  GlaxoSmithKline, a global leader in the research-based pharmaceutical  industry," said Prasco chief executive Thomas Arington.